Ancora Advisors, LLC Amgen Inc Transaction History

Ancora Advisors, LLC

$4.06 Billion
Q3 2024

A detailed history of Ancora Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Ancora Advisors, LLC holds 35,692 shares of AMGN stock, worth $10.1 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

35,692

Previous 36,108 1.15%

Holding current value

$10.1 Million

Previous $11.3 Million 1.94%

% of portfolio

0.28%

Previous 0.3%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $128,702 - $140,350	-416 Reduced 1.15%	35,692 $11.5 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $130,324 - $158,377	-496 Reduced 1.36%	36,108 $11.3 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $246,016 - $296,972	-915 Reduced 2.44%	36,604 $10.4 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $155,209 - $175,095	-607 Reduced 1.59%	37,519 $10.8 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $114,791 - $142,516	-525 Reduced 1.36%	38,126 $10.2 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $299,120 - $353,704	-1,396 Reduced 3.49%	38,651 $8.58 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $205,694 - $250,707	-911 Reduced 2.22%	40,047 $9.68 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $224,449 - $285,189	-980 Reduced 2.34%	40,958 $10.8 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $55,666 - $62,781	-248 Reduced 0.59%	41,938 $9.45 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $190,566 - $212,067	-826 Reduced 1.92%	42,186 $10.3 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $18.5 Million - $20.4 Million	-84,218 Reduced 66.19%	43,012 $10.4 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $17.8 Million - $19.7 Million	81,299 Added 177.0%	127,230 $31.7 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $503,564 - $576,283	-2,532 Reduced 5.22%	45,931 $10.3 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $15.4 Million - $18 Million	-72,360 Reduced 59.89%	48,463 $10.3 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $1.5 Million - $1.66 Million	-6,407 Reduced 5.04%	120,823 $29.5 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $302,019 - $351,954	-1,361 Reduced 1.06%	127,230 $31.7 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $745,429 - $887,673	-3,445 Reduced 2.61%	128,591 $29.6 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $383,887 - $426,914	1,636 Added 1.25%	132,036 $33.6 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $623,892 - $765,601	3,154 Added 2.48%	130,400 $30.8 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $2.09 Million - $2.77 Million	11,441 Added 9.88%	127,246 $25.8 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $4.16 Million - $5.35 Million	21,997 Added 23.45%	115,805 $27.9 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $975,364 - $1.17 Million	5,602 Added 6.35%	93,808 $18.2 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $879,342 - $1.03 Million	5,275 Added 6.36%	88,206 $16.3 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $15 Million - $16.9 Million	82,931 New	82,931 $15.8 Million
Q4 2018 Feb 15, 2019	SELL	$178.4 - $208.25 $4.1 Million - $4.79 Million	-23,003 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $94,312 - $106,325	509 Added 2.26%	23,003 $4.77 Million
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $307,524 - $345,416	1,852 Added 8.97%	22,494 $4.15 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $3.5 Million - $4.09 Million	20,642 New	20,642 $3.52 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $2.51 Million - $2.8 Million	-14,856 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $2.49 Million - $2.84 Million	14,856	14,856 $2.77 Million

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Account

Ancora Advisors, LLC Amgen Inc Transaction History